Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
144.8 USD | +1.42% | +5.05% | +3.91% |
May. 01 | Agilent Technologies Says Padraig McDonnell Assumes CEO Role | MT |
May. 01 | Agilent Technologies Appoints Padraig McDonnell CEO | MT |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.24 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.71% | 41.85B | A | ||
+8.07% | 219B | B | ||
+7.87% | 185B | B- | ||
+12.75% | 135B | B- | ||
-1.18% | 62.21B | A- | ||
+4.88% | 51.01B | B+ | ||
+11.59% | 51.28B | B+ | ||
+4.90% | 37.02B | - | ||
+23.75% | 31.27B | B+ | ||
+15.13% | 23.66B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- A Stock
- Ratings Agilent Technologies, Inc.